{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T22:34:16Z","timestamp":1793658856870,"version":"4.5.1"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,1]]},"abstract":"<jats:sec>\n            <jats:title>OBJECTIVE:<\/jats:title>\n            <jats:p>To summarize available data on the effectiveness and safety of single-agent misoprostol for medical abortion in the first trimester.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DATA SOURCES:<\/jats:title>\n            <jats:p>We searched MEDLINE, CABI, Cochrane, EMBASE, LILACS, the Web of Science, and ClinicalTrials.gov for English-language studies that evaluated misoprostol alone for abortion of a viable pregnancy in the first trimester.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS OF STUDY SELECTION:<\/jats:title>\n            <jats:p>Our search yielded 1,562 citations, of which 38 included data from 53 trial groups that met our inclusion and exclusion criteria.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>TABULATION, INTEGRATION, AND RESULTS:<\/jats:title>\n            <jats:p>We abstracted data about each trial group, including study characteristics, treatment regimen, clinical protocol, number of women treated and followed, and numbers with outcomes of interest. We used meta-analytic methods and logistic regression to examine factors associated with surgical intervention after treatment. Among all 12,829 evaluable women, 2,536 (meta-analytic estimate 22.0%, 95% CI 18.8\u201325.5%) had surgical uterine evacuation. Multiple factors were significantly associated with this proportion, including misoprostol amount per dose and route of administration, loss to follow-up rate, publication date, geographic region, number of misoprostol doses, duration of dosing, and time between dosing and evaluation. Of 6,359 evaluable women, 384 (meta-analytic estimate 6.8%, 95% CI 5.3\u20138.5%) had ongoing pregnancies. At most 26 of 12,184 evaluable women (meta-analytic estimate 0.7%, 95% CI 0.4\u20131.0%) were transfused or hospitalized for abortion-related reasons. In trials that provided satisfaction data, most women were satisfied or very satisfied with the treatment (meta-analytic estimate 78%, 95% CI 71\u201385%).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSIONS:<\/jats:title>\n            <jats:p>Misoprostol alone is effective and safe and is a reasonable option for women seeking abortion in the first trimester. Research is indicated to further refine the regimen and to establish efficacy in the late first trimester.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>SYSTEMATIC REVIEW REGISTRATION:<\/jats:title>\n            <jats:p>PROSPERO, CRD42018083589.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/aog.0000000000003017","type":"journal-article","created":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T21:48:29Z","timestamp":1544132909000},"page":"137-147","source":"Crossref","is-referenced-by-count":77,"title":["Efficacy of Misoprostol Alone for First-Trimester Medical Abortion"],"prefix":"10.1097","volume":"133","author":[{"given":"Elizabeth G.","family":"Raymond","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margo S.","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Weaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230711","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.contraception.2012.06.011","article-title":"First-trimester medical abortion with mifepristone 200 mg and misoprostol: a systematic review","volume":"87","author":"Raymond","year":"2013","journal-title":"Contraception"},{"key":"R2-20230711","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/AOG.0000000000000897","article-title":"Mifepristone with buccal misoprostol for medical abortion: a systematic review","volume":"126","author":"Chen","year":"2015","journal-title":"Obstet Gynecol"},{"key":"R3-20230711","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.contraception.2015.06.018","article-title":"Outpatient medical abortion is safe and effective through 70 days gestation","volume":"92","author":"Abbas","year":"2015","journal-title":"Contraception"},{"key":"R4-20230711","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1056\/NEJMsb1612526","article-title":"Sixteen years of overregulation: time to unburden mifeprex","volume":"376","author":"Raymond","year":"2017","journal-title":"N Engl J Med"},{"key":"R5-20230711","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ijgo.2006.09.009","article-title":"Alternatives to mifepristone for early medical abortion","volume":"96","author":"Moreno-Ruiz","year":"2007","journal-title":"Int J Gynaecol Obstet"},{"key":"R6-20230711","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"R7-20230711","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v036.i03","article-title":"Conducting meta-analyses in R with the metafor package","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"J Stat Softw"},{"key":"R8-20230711","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1471-0528.2007.01274.x","article-title":"Does methotrexate confer a significant advantage over misoprostol alone for early medical abortion? A retrospective analysis of 8678 abortions","volume":"114","author":"Aldrich","year":"2007","journal-title":"BJOG"},{"issue":"suppl","key":"R9-20230711","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0968-8080(04)24010-1","article-title":"Misoprostol alone for early medical abortion in a Latin American clinic setting","volume":"12","author":"Billings","year":"2004","journal-title":"Reprod Health Matters"},{"key":"R10-20230711","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.contraception.2005.02.008","article-title":"Misoprostol alone for early abortion: an evaluation of seven potential regimens","volume":"72","author":"Blanchard","year":"2005","journal-title":"Contraception"},{"key":"R11-20230711","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ijgo.2012.03.039","article-title":"Comparison of misoprostol-only and combined mifepristone-misoprostol regimens for home-based early medical abortion in Tunisia and Vietnam","volume":"118","author":"Blum","year":"2012","journal-title":"Int J Gynecol Obstet"},{"key":"R12-20230711","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ijgo.2010.01.010","article-title":"Anthropometric characteristics and success rates of oral or vaginal misoprostol for pregnancy termination in the first and second trimesters","volume":"109","author":"van Bogaert","year":"2010","journal-title":"Int J Gynaecol Obstet"},{"key":"R13-20230711","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1080\/01443610701478967","article-title":"Efficacy of a single misoprostol regimen in the first and second trimester termination of pregnancy","volume":"27","author":"van Bogaert","year":"2007","journal-title":"J Obstet Gynaecol"},{"key":"R14-20230711","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.contraception.2004.03.007","article-title":"Misoprostol as the primary agent for medical abortion in a low-income urban setting","volume":"70","author":"Borgatta","year":"2004","journal-title":"Contraception"},{"key":"R15-20230711","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/0010-7824(96)00044-3","article-title":"Evaluation of the effectiveness of vaginal misoprostol to induce first trimester abortion","volume":"53","author":"Bugalho","year":"1996","journal-title":"Contraception"},{"key":"R16-20230711","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0010-7824(99)00116-X","article-title":"Termination of pregnancies of <6 weeks gestation with a single dose of 800 microg of vaginal misoprostol","volume":"61","author":"Bugalho","year":"2000","journal-title":"Contraception"},{"key":"R17-20230711","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0010-7824(98)00037-7","article-title":"Vaginal misoprostol for late first trimester abortion","volume":"57","author":"Carbonell Esteve","year":"1998","journal-title":"Contraception"},{"key":"R18-20230711","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1080\/13625180008500367","article-title":"Vaginal misoprostol 600 microg for early abortion","volume":"5","author":"Carbonell Esteve","year":"2000","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"R19-20230711","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0010-7824(99)00032-3","article-title":"Early abortion with 800 micrograms of misoprostol by the vaginal route","volume":"59","author":"Carbonell Esteve","year":"1999","journal-title":"Contraception"},{"key":"R20-20230711","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0010-7824(01)00189-5","article-title":"Vaginal misoprostol 1000 microg for early abortion","volume":"63","author":"Carbonell","year":"2001","journal-title":"Contraception"},{"key":"R21-20230711","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0010-7824(03)00043-X","article-title":"Oral and vaginal misoprostol 800 microg every 8 h for early abortion","volume":"67","author":"Carbonell","year":"2003","journal-title":"Contraception"},{"key":"R22-20230711","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0010-7824(97)00020-6","article-title":"The use of misoprostol for termination of early pregnancy","volume":"55","author":"Carbonell","year":"1997","journal-title":"Contraception"},{"key":"R23-20230711","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3109\/13625189709167474","article-title":"The use of misoprostol for abortion at < or = 9 weeks' gestation","volume":"2","author":"Carbonell","year":"1997","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"R24-20230711","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1001\/jama.1994.03520150058037","article-title":"Methotrexate and misoprostol vs misoprostol alone for early abortion. A randomized controlled trial","volume":"272","author":"Creinin","year":"1994","journal-title":"JAMA"},{"key":"R25-20230711","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1080\/01443610701497561","article-title":"Pregnancy termination using vaginal misoprostol in women with more than one caesarean section","volume":"27","author":"Daponte","year":"2007","journal-title":"J Obstet Gynaecol"},{"key":"R26-20230711","first-page":"32","article-title":"Misoprostol and first trimester pregnancy termination","volume":"35","author":"Grapsas","year":"2008","journal-title":"Clin Exp Obstet Gynecol"},{"key":"R27-20230711","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/S0140-6736(07)60914-3","article-title":"Efficacy of two intervals and two routes of administration of misoprostol for termination of early pregnancy: a randomised controlled equivalence trial","volume":"369","author":"von Hertzen","year":"2007","journal-title":"Lancet"},{"key":"R28-20230711","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/humrep\/17.6.1477","article-title":"A prospective randomized, double-blinded, placebo-controlled trial comparing mifepristone and vaginal misoprostol to vaginal misoprostol alone for elective termination of early pregnancy","volume":"17","author":"Jain","year":"2002","journal-title":"Hum Reprod"},{"key":"R29-20230711","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0010-7824(01)00193-7","article-title":"Early pregnancy termination with vaginal misoprostol combined with loperamide and acetaminophen prophylaxis","volume":"63","author":"Jain","year":"2001","journal-title":"Contraception"},{"key":"R30-20230711","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/S0002-9378(99)70380-7","article-title":"Early pregnancy termination with intravaginally administered sodium chloride solution-moistened misoprostol tablets: historical comparison with mifepristone and oral misoprostol","volume":"181","author":"Jain","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"R31-20230711","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0010-7824(99)00105-5","article-title":"A comparison of tamoxifen and misoprostol to misoprostol alone for early pregnancy termination","volume":"60","author":"Jain","year":"2000","journal-title":"Contraception"},{"key":"R32-20230711","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/0010-7824(96)00043-1","article-title":"The use of misoprostol for termination of early pregnancy","volume":"53","author":"Koopersmith","year":"1996","journal-title":"Contraception"},{"key":"R33-20230711","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0377-1237(05)80012-7","article-title":"Termination of pregnancy in first trimester\u2014 medical option","volume":"61","author":"Kumar","year":"2005","journal-title":"Med J Armed Forces India"},{"key":"R34-20230711","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/AOG.0b013e3182073fbf","article-title":"Misoprostol with or without letrozole pretreatment for termination of pregnancy: a randomized controlled trial","volume":"117","author":"Lee","year":"2011","journal-title":"Obstet Gynecol"},{"key":"R35-20230711","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1093\/humrep\/15.5.1159","article-title":"Vaginal misoprostol alone for medical abortion up to 9 weeks of gestation: efficacy and acceptability","volume":"15","author":"Ngai","year":"2000","journal-title":"Hum Reprod"},{"key":"R36-20230711","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.contraception.2010.09.002","article-title":"Comparing two early medical abortion regimens: mifepristone+misoprostol vs. misoprostol alone","volume":"83","author":"Ngoc","year":"2011","journal-title":"Contraception"},{"key":"R37-20230711","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0010-7824(99)00047-5","article-title":"Methotrexate and misoprostol used alone or in combination for early abortion","volume":"59","author":"Ozeren","year":"1999","journal-title":"Contraception"},{"key":"R38-20230711","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.fertnstert.2007.11.028","article-title":"Early termination of pregnancy by single-dose 800 microg misoprostol compared with surgical evacuation","volume":"91","author":"Prasad","year":"2009","journal-title":"Fertil Steril"},{"key":"R39-20230711","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1046\/j.1471-0528.2003.02225.x","article-title":"A viable alternative to surgical vacuum aspiration: repeated doses of intravaginal misoprostol over 9 hours for medical termination of pregnancies up to eight weeks","volume":"110","author":"Singh","year":"2003","journal-title":"BJOG"},{"key":"R40-20230711","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1023\/A:1006701600323","article-title":"Pilot study on the use of repeated doses of misoprostol in termination of pregnancy at less than 9 weeks of gestation","volume":"15","author":"Tang","year":"1999","journal-title":"Adv Contracept"},{"key":"R41-20230711","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1089\/jwh.2016.6144","article-title":"Building bridges: a case for community health worker provision of misoprostol-only abortion in the first trimester","volume":"27","author":"Tebbets","year":"2018","journal-title":"J Womens Health (Larchmt)"},{"key":"R42-20230711","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/13625180008500410","article-title":"Misoprostol for abortion up to 9 weeks' gestation in adolescents","volume":"5","author":"Velazco","year":"2000","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"R43-20230711","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ijgo.2006.07.015","article-title":"Misoprostol alone vs. methotrexate followed by misoprostol for early abortion","volume":"95","author":"Wiebe","year":"2006","journal-title":"Int J Gynaecol Obstet"},{"key":"R44-20230711","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1093\/humrep\/17.12.3079","article-title":"Early pregnancy termination with vaginal misoprostol before and after 42 days gestation","volume":"17","author":"Zikopoulos","year":"2002","journal-title":"Hum Reprod"},{"key":"R45-20230711","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jogoh.2017.11.002","article-title":"Evaluation of effect of letrozole prior to misoprostol in comparison with misoprostol alone in success rate of induced abortion","volume":"47","author":"Behroozi-Lak","year":"2018","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"R46-20230711","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1093\/humrep\/der303","article-title":"A randomized comparison of pharmacokinetics of a single vaginal dose of dry misoprostol or misoprostol moistened with normal saline or with acetic acid","volume":"26","author":"Lee","year":"2011","journal-title":"Hum Reprod"},{"key":"R47-20230711","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ijgo.2003.11.007","article-title":"Misoprostol wetting with acetic acid for pre-abortion cervical priming","volume":"85","author":"Kelekci","year":"2004","journal-title":"Int J Gynaecol Obstet"},{"key":"R48-20230711","first-page":"125","article-title":"Misoprostol administration in medical abortion. A comparison of three regimens","volume":"46","author":"Wiebe","year":"2001","journal-title":"J Reprod Med"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006250-201901000-00019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T19:35:53Z","timestamp":1689104153000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006250-201901000-00019"}},"subtitle":["A Systematic Review"],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000003017","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]}}}